Paper837501
Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
Vogel WM and 3 others. Circulation, 1977. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog. Papers, record 837501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/837501
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Coronary Disease | Major topic |
| Methylprednisolone | Major topic |
| Myocardial Infarction | Major topic |
| Animals | |
| Arrhythmias, Cardiac | |
| Creatine Kinase | |
| Dogs | |
| Drug Evaluation, Preclinical | |
| Hemodynamics | |
| L-Lactate Dehydrogenase | |
| Male | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23224061 | Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. | Circulation | 2013 | https://conductscience.org/library/papers/23224061 | PubMed |
| 7396811 | Mechanism of the beneficial effect of dexamethasone on myocardial cell integrity in acure myocardial ischemia. | Basic Res Cardiol | 1980 | https://conductscience.org/library/papers/7396811 | PubMed |
| 7364454 | Reduction of cell injury in hypoxic cultures of rat myocardial cells by methylprednisolone. | In Vitro | 1980 | https://conductscience.org/library/papers/7364454 | PubMed |
| 7092776 | Ineffectiveness of methylprednisolone to reduce infarct size in experimental coronary occlusion. | Basic Res Cardiol | 1982 | https://conductscience.org/library/papers/7092776 | PubMed |
| 3571494 | Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3571494 | PubMed |
| 2938453 | Glucocorticoids in myocardial and cerebral infarction. | Agents Actions | 1986 | https://conductscience.org/library/papers/2938453 | PubMed |
| 701478 | Influence of methylprednisolone of the sequential redistribution of cathepsin D and other lysosomal enzymes during myocardial ischemia in rabbits. | J Clin Invest | 1978 | https://conductscience.org/library/papers/701478 | PubMed |
| 641137 | Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. | J Clin Invest | 1978 | https://conductscience.org/library/papers/641137 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/837501
GET https://conductscience.org/api/papers/v1/837501/authors